# Clinical Efficacy of Sertraline Augmented With Gabapentin in Depressed, Recently Abstinent Cocaine-dependent Humans

> **NCT00654953** · PHASE2 · COMPLETED · sponsor: **University of Arkansas** · enrollment: 102 (actual)

## Conditions studied

- Cocaine Dependence
- Depressive Symptoms

## Interventions

- **DRUG:** sertraline
- **DRUG:** Placebo
- **DRUG:** gabapentin

## Key facts

- **NCT ID:** NCT00654953
- **Lead sponsor:** University of Arkansas
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2011-04-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00654953

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00654953, "Clinical Efficacy of Sertraline Augmented With Gabapentin in Depressed, Recently Abstinent Cocaine-dependent Humans". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00654953. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*